BX Swiss TOP 30 CHF
1.228,04
PKT
-12,73
PKT
-1,03
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
Datum | Rating | Analyst | |
---|---|---|---|
18.10.18 | Novartis Neutral | JP Morgan Chase & Co. | |
18.10.18 | Nestlé overweight | JP Morgan Chase & Co. | |
18.10.18 | Novartis buy | Baader Bank | |
18.10.18 | Nestlé Outperform | RBC Capital Markets | |
18.10.18 | Roche buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
18.10.18 | Roche Underperform | Credit Suisse Group | |
17.10.18 | UBS Outperform | Credit Suisse Group | |
17.10.18 | Roche Neutral | UBS AG | |
17.10.18 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
17.10.18 | Roche buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
17.10.18 | Roche buy | Baader Bank | |
17.10.18 | Roche overweight | JP Morgan Chase & Co. | |
17.10.18 | Roche buy | Jefferies & Company Inc. | |
17.10.18 | Novartis Neutral | JP Morgan Chase & Co. | |
17.10.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
16.10.18 | Nestlé overweight | Morgan Stanley | |
16.10.18 | Zurich Insurance Neutral | UBS AG | |
16.10.18 | Swiss Re Sell | UBS AG | |
16.10.18 | Swiss Re buy | Goldman Sachs Group Inc. | |
15.10.18 | Holcim buy | Citigroup Corp. | |
15.10.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
15.10.18 | Roche overweight | JP Morgan Chase & Co. | |
15.10.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
15.10.18 | Holcim overweight | Morgan Stanley | |
12.10.18 | UBS Underweight | Barclays Capital | |
12.10.18 | UBS Equal weight | Barclays Capital | |
12.10.18 | Novartis buy | Baader Bank | |
12.10.18 | UBS Hold | Deutsche Bank AG | |
12.10.18 | UBS buy | Deutsche Bank AG | |
12.10.18 | Swiss Re kaufen | Barclays Capital | |
11.10.18 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
11.10.18 | Novartis Neutral | JP Morgan Chase & Co. | |
11.10.18 | Novartis Neutral | JP Morgan Chase & Co. | |
11.10.18 | Swiss Re overweight | JP Morgan Chase & Co. | |
10.10.18 | Nestlé overweight | JP Morgan Chase & Co. | |
10.10.18 | Givaudan overweight | JP Morgan Chase & Co. | |
10.10.18 | Swiss Re Sell | UBS AG | |
10.10.18 | Novartis Neutral | Goldman Sachs Group Inc. | |
10.10.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
09.10.18 | Givaudan buy | Baader Bank |